questionsmedicales.fr
Lipides
Lipides membranaires
Sphingolipides
Sphingolipides : Questions médicales fréquentes
Termes MeSH sélectionnés :
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Sphingolipides : Questions médicales les plus fréquentes",
"headline": "Sphingolipides : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Sphingolipides : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-06-13",
"dateModified": "2025-03-10",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Sphingolipides"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Lipides membranaires",
"url": "https://questionsmedicales.fr/mesh/D008563",
"about": {
"@type": "MedicalCondition",
"name": "Lipides membranaires",
"code": {
"@type": "MedicalCode",
"code": "D008563",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D10.570"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Glycosphingolipides",
"alternateName": "Glycosphingolipids",
"url": "https://questionsmedicales.fr/mesh/D006028",
"about": {
"@type": "MedicalCondition",
"name": "Glycosphingolipides",
"code": {
"@type": "MedicalCode",
"code": "D006028",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D10.570.877.360"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Glycosphingolipides acides",
"alternateName": "Acidic Glycosphingolipids",
"url": "https://questionsmedicales.fr/mesh/D020384",
"about": {
"@type": "MedicalCondition",
"name": "Glycosphingolipides acides",
"code": {
"@type": "MedicalCode",
"code": "D020384",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D10.570.877.360.025"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Gangliosides",
"alternateName": "Gangliosides",
"url": "https://questionsmedicales.fr/mesh/D005732",
"about": {
"@type": "MedicalCondition",
"name": "Gangliosides",
"code": {
"@type": "MedicalCode",
"code": "D005732",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D10.570.877.360.025.475"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Ganglioside GM1",
"alternateName": "G(M1) Ganglioside",
"url": "https://questionsmedicales.fr/mesh/D005677",
"about": {
"@type": "MedicalCondition",
"name": "Ganglioside GM1",
"code": {
"@type": "MedicalCode",
"code": "D005677",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D10.570.877.360.025.475.390"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Ganglioside GM2",
"alternateName": "G(M2) Ganglioside",
"url": "https://questionsmedicales.fr/mesh/D005678",
"about": {
"@type": "MedicalCondition",
"name": "Ganglioside GM2",
"code": {
"@type": "MedicalCode",
"code": "D005678",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D10.570.877.360.025.475.400"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Ganglioside GM3",
"alternateName": "G(M3) Ganglioside",
"url": "https://questionsmedicales.fr/mesh/D005679",
"about": {
"@type": "MedicalCondition",
"name": "Ganglioside GM3",
"code": {
"@type": "MedicalCode",
"code": "D005679",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D10.570.877.360.025.475.510"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Ganglioside GM1",
"alternateName": "G(M1) Ganglioside",
"url": "https://questionsmedicales.fr/mesh/D005677",
"about": {
"@type": "MedicalCondition",
"name": "Ganglioside GM1",
"code": {
"@type": "MedicalCode",
"code": "D005677",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D10.570.877.360.025.475.390"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Ganglioside GM2",
"alternateName": "G(M2) Ganglioside",
"url": "https://questionsmedicales.fr/mesh/D005678",
"about": {
"@type": "MedicalCondition",
"name": "Ganglioside GM2",
"code": {
"@type": "MedicalCode",
"code": "D005678",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D10.570.877.360.025.475.400"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Ganglioside GM3",
"alternateName": "G(M3) Ganglioside",
"url": "https://questionsmedicales.fr/mesh/D005679",
"about": {
"@type": "MedicalCondition",
"name": "Ganglioside GM3",
"code": {
"@type": "MedicalCode",
"code": "D005679",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D10.570.877.360.025.475.510"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Sulfoglycosphingolipides",
"alternateName": "Sulfoglycosphingolipids",
"url": "https://questionsmedicales.fr/mesh/D013433",
"about": {
"@type": "MedicalCondition",
"name": "Sulfoglycosphingolipides",
"code": {
"@type": "MedicalCode",
"code": "D013433",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D10.570.877.360.025.837"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Gangliosides",
"alternateName": "Gangliosides",
"url": "https://questionsmedicales.fr/mesh/D005732",
"about": {
"@type": "MedicalCondition",
"name": "Gangliosides",
"code": {
"@type": "MedicalCode",
"code": "D005732",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D10.570.877.360.025.475"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Ganglioside GM1",
"alternateName": "G(M1) Ganglioside",
"url": "https://questionsmedicales.fr/mesh/D005677",
"about": {
"@type": "MedicalCondition",
"name": "Ganglioside GM1",
"code": {
"@type": "MedicalCode",
"code": "D005677",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D10.570.877.360.025.475.390"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Ganglioside GM2",
"alternateName": "G(M2) Ganglioside",
"url": "https://questionsmedicales.fr/mesh/D005678",
"about": {
"@type": "MedicalCondition",
"name": "Ganglioside GM2",
"code": {
"@type": "MedicalCode",
"code": "D005678",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D10.570.877.360.025.475.400"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Ganglioside GM3",
"alternateName": "G(M3) Ganglioside",
"url": "https://questionsmedicales.fr/mesh/D005679",
"about": {
"@type": "MedicalCondition",
"name": "Ganglioside GM3",
"code": {
"@type": "MedicalCode",
"code": "D005679",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D10.570.877.360.025.475.510"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Ganglioside GM1",
"alternateName": "G(M1) Ganglioside",
"url": "https://questionsmedicales.fr/mesh/D005677",
"about": {
"@type": "MedicalCondition",
"name": "Ganglioside GM1",
"code": {
"@type": "MedicalCode",
"code": "D005677",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D10.570.877.360.025.475.390"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Ganglioside GM2",
"alternateName": "G(M2) Ganglioside",
"url": "https://questionsmedicales.fr/mesh/D005678",
"about": {
"@type": "MedicalCondition",
"name": "Ganglioside GM2",
"code": {
"@type": "MedicalCode",
"code": "D005678",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D10.570.877.360.025.475.400"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Ganglioside GM3",
"alternateName": "G(M3) Ganglioside",
"url": "https://questionsmedicales.fr/mesh/D005679",
"about": {
"@type": "MedicalCondition",
"name": "Ganglioside GM3",
"code": {
"@type": "MedicalCode",
"code": "D005679",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D10.570.877.360.025.475.510"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Sulfoglycosphingolipides",
"alternateName": "Sulfoglycosphingolipids",
"url": "https://questionsmedicales.fr/mesh/D013433",
"about": {
"@type": "MedicalCondition",
"name": "Sulfoglycosphingolipides",
"code": {
"@type": "MedicalCode",
"code": "D013433",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D10.570.877.360.025.837"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Glycosphingolipides neutres",
"alternateName": "Neutral Glycosphingolipids",
"url": "https://questionsmedicales.fr/mesh/D020383",
"about": {
"@type": "MedicalCondition",
"name": "Glycosphingolipides neutres",
"code": {
"@type": "MedicalCode",
"code": "D020383",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D10.570.877.360.612"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Céramides",
"alternateName": "Ceramides",
"url": "https://questionsmedicales.fr/mesh/D002518",
"about": {
"@type": "MedicalCondition",
"name": "Céramides",
"code": {
"@type": "MedicalCode",
"code": "D002518",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D10.570.877.360.612.200"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Cérébrosides",
"alternateName": "Cerebrosides",
"url": "https://questionsmedicales.fr/mesh/D002554",
"about": {
"@type": "MedicalCondition",
"name": "Cérébrosides",
"code": {
"@type": "MedicalCode",
"code": "D002554",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D10.570.877.360.612.200.250"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Galactosylcéramides",
"alternateName": "Galactosylceramides",
"url": "https://questionsmedicales.fr/mesh/D005699",
"about": {
"@type": "MedicalCondition",
"name": "Galactosylcéramides",
"code": {
"@type": "MedicalCode",
"code": "D005699",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D10.570.877.360.612.200.250.450"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Glucosylcéramides",
"alternateName": "Glucosylceramides",
"url": "https://questionsmedicales.fr/mesh/D005963",
"about": {
"@type": "MedicalCondition",
"name": "Glucosylcéramides",
"code": {
"@type": "MedicalCode",
"code": "D005963",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D10.570.877.360.612.200.250.490"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Galactosylcéramides",
"alternateName": "Galactosylceramides",
"url": "https://questionsmedicales.fr/mesh/D005699",
"about": {
"@type": "MedicalCondition",
"name": "Galactosylcéramides",
"code": {
"@type": "MedicalCode",
"code": "D005699",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D10.570.877.360.612.200.250.450"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Glucosylcéramides",
"alternateName": "Glucosylceramides",
"url": "https://questionsmedicales.fr/mesh/D005963",
"about": {
"@type": "MedicalCondition",
"name": "Glucosylcéramides",
"code": {
"@type": "MedicalCode",
"code": "D005963",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D10.570.877.360.612.200.250.490"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Globosides",
"alternateName": "Globosides",
"url": "https://questionsmedicales.fr/mesh/D005915",
"about": {
"@type": "MedicalCondition",
"name": "Globosides",
"code": {
"@type": "MedicalCode",
"code": "D005915",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D10.570.877.360.612.200.425"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Lactosylcéramides",
"alternateName": "Lactosylceramides",
"url": "https://questionsmedicales.fr/mesh/D007790",
"about": {
"@type": "MedicalCondition",
"name": "Lactosylcéramides",
"code": {
"@type": "MedicalCode",
"code": "D007790",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D10.570.877.360.612.200.612"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Trihexosylcéramide",
"alternateName": "Trihexosylceramides",
"url": "https://questionsmedicales.fr/mesh/D014281",
"about": {
"@type": "MedicalCondition",
"name": "Trihexosylcéramide",
"code": {
"@type": "MedicalCode",
"code": "D014281",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D10.570.877.360.612.200.906"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Cérébrosides",
"alternateName": "Cerebrosides",
"url": "https://questionsmedicales.fr/mesh/D002554",
"about": {
"@type": "MedicalCondition",
"name": "Cérébrosides",
"code": {
"@type": "MedicalCode",
"code": "D002554",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D10.570.877.360.612.200.250"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Galactosylcéramides",
"alternateName": "Galactosylceramides",
"url": "https://questionsmedicales.fr/mesh/D005699",
"about": {
"@type": "MedicalCondition",
"name": "Galactosylcéramides",
"code": {
"@type": "MedicalCode",
"code": "D005699",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D10.570.877.360.612.200.250.450"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Glucosylcéramides",
"alternateName": "Glucosylceramides",
"url": "https://questionsmedicales.fr/mesh/D005963",
"about": {
"@type": "MedicalCondition",
"name": "Glucosylcéramides",
"code": {
"@type": "MedicalCode",
"code": "D005963",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D10.570.877.360.612.200.250.490"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Galactosylcéramides",
"alternateName": "Galactosylceramides",
"url": "https://questionsmedicales.fr/mesh/D005699",
"about": {
"@type": "MedicalCondition",
"name": "Galactosylcéramides",
"code": {
"@type": "MedicalCode",
"code": "D005699",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D10.570.877.360.612.200.250.450"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Glucosylcéramides",
"alternateName": "Glucosylceramides",
"url": "https://questionsmedicales.fr/mesh/D005963",
"about": {
"@type": "MedicalCondition",
"name": "Glucosylcéramides",
"code": {
"@type": "MedicalCode",
"code": "D005963",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D10.570.877.360.612.200.250.490"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Globosides",
"alternateName": "Globosides",
"url": "https://questionsmedicales.fr/mesh/D005915",
"about": {
"@type": "MedicalCondition",
"name": "Globosides",
"code": {
"@type": "MedicalCode",
"code": "D005915",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D10.570.877.360.612.200.425"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Lactosylcéramides",
"alternateName": "Lactosylceramides",
"url": "https://questionsmedicales.fr/mesh/D007790",
"about": {
"@type": "MedicalCondition",
"name": "Lactosylcéramides",
"code": {
"@type": "MedicalCode",
"code": "D007790",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D10.570.877.360.612.200.612"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Trihexosylcéramide",
"alternateName": "Trihexosylceramides",
"url": "https://questionsmedicales.fr/mesh/D014281",
"about": {
"@type": "MedicalCondition",
"name": "Trihexosylcéramide",
"code": {
"@type": "MedicalCode",
"code": "D014281",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D10.570.877.360.612.200.906"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Sphingomyéline",
"alternateName": "Sphingomyelins",
"url": "https://questionsmedicales.fr/mesh/D013109",
"about": {
"@type": "MedicalCondition",
"name": "Sphingomyéline",
"code": {
"@type": "MedicalCode",
"code": "D013109",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D10.570.877.360.612.870"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Céramides",
"alternateName": "Ceramides",
"url": "https://questionsmedicales.fr/mesh/D002518",
"about": {
"@type": "MedicalCondition",
"name": "Céramides",
"code": {
"@type": "MedicalCode",
"code": "D002518",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D10.570.877.360.612.200"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Cérébrosides",
"alternateName": "Cerebrosides",
"url": "https://questionsmedicales.fr/mesh/D002554",
"about": {
"@type": "MedicalCondition",
"name": "Cérébrosides",
"code": {
"@type": "MedicalCode",
"code": "D002554",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D10.570.877.360.612.200.250"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Galactosylcéramides",
"alternateName": "Galactosylceramides",
"url": "https://questionsmedicales.fr/mesh/D005699",
"about": {
"@type": "MedicalCondition",
"name": "Galactosylcéramides",
"code": {
"@type": "MedicalCode",
"code": "D005699",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D10.570.877.360.612.200.250.450"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Glucosylcéramides",
"alternateName": "Glucosylceramides",
"url": "https://questionsmedicales.fr/mesh/D005963",
"about": {
"@type": "MedicalCondition",
"name": "Glucosylcéramides",
"code": {
"@type": "MedicalCode",
"code": "D005963",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D10.570.877.360.612.200.250.490"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Galactosylcéramides",
"alternateName": "Galactosylceramides",
"url": "https://questionsmedicales.fr/mesh/D005699",
"about": {
"@type": "MedicalCondition",
"name": "Galactosylcéramides",
"code": {
"@type": "MedicalCode",
"code": "D005699",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D10.570.877.360.612.200.250.450"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Glucosylcéramides",
"alternateName": "Glucosylceramides",
"url": "https://questionsmedicales.fr/mesh/D005963",
"about": {
"@type": "MedicalCondition",
"name": "Glucosylcéramides",
"code": {
"@type": "MedicalCode",
"code": "D005963",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D10.570.877.360.612.200.250.490"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Globosides",
"alternateName": "Globosides",
"url": "https://questionsmedicales.fr/mesh/D005915",
"about": {
"@type": "MedicalCondition",
"name": "Globosides",
"code": {
"@type": "MedicalCode",
"code": "D005915",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D10.570.877.360.612.200.425"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Lactosylcéramides",
"alternateName": "Lactosylceramides",
"url": "https://questionsmedicales.fr/mesh/D007790",
"about": {
"@type": "MedicalCondition",
"name": "Lactosylcéramides",
"code": {
"@type": "MedicalCode",
"code": "D007790",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D10.570.877.360.612.200.612"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Trihexosylcéramide",
"alternateName": "Trihexosylceramides",
"url": "https://questionsmedicales.fr/mesh/D014281",
"about": {
"@type": "MedicalCondition",
"name": "Trihexosylcéramide",
"code": {
"@type": "MedicalCode",
"code": "D014281",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D10.570.877.360.612.200.906"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Cérébrosides",
"alternateName": "Cerebrosides",
"url": "https://questionsmedicales.fr/mesh/D002554",
"about": {
"@type": "MedicalCondition",
"name": "Cérébrosides",
"code": {
"@type": "MedicalCode",
"code": "D002554",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D10.570.877.360.612.200.250"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Galactosylcéramides",
"alternateName": "Galactosylceramides",
"url": "https://questionsmedicales.fr/mesh/D005699",
"about": {
"@type": "MedicalCondition",
"name": "Galactosylcéramides",
"code": {
"@type": "MedicalCode",
"code": "D005699",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D10.570.877.360.612.200.250.450"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Glucosylcéramides",
"alternateName": "Glucosylceramides",
"url": "https://questionsmedicales.fr/mesh/D005963",
"about": {
"@type": "MedicalCondition",
"name": "Glucosylcéramides",
"code": {
"@type": "MedicalCode",
"code": "D005963",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D10.570.877.360.612.200.250.490"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Galactosylcéramides",
"alternateName": "Galactosylceramides",
"url": "https://questionsmedicales.fr/mesh/D005699",
"about": {
"@type": "MedicalCondition",
"name": "Galactosylcéramides",
"code": {
"@type": "MedicalCode",
"code": "D005699",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D10.570.877.360.612.200.250.450"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Glucosylcéramides",
"alternateName": "Glucosylceramides",
"url": "https://questionsmedicales.fr/mesh/D005963",
"about": {
"@type": "MedicalCondition",
"name": "Glucosylcéramides",
"code": {
"@type": "MedicalCode",
"code": "D005963",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D10.570.877.360.612.200.250.490"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Globosides",
"alternateName": "Globosides",
"url": "https://questionsmedicales.fr/mesh/D005915",
"about": {
"@type": "MedicalCondition",
"name": "Globosides",
"code": {
"@type": "MedicalCode",
"code": "D005915",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D10.570.877.360.612.200.425"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Lactosylcéramides",
"alternateName": "Lactosylceramides",
"url": "https://questionsmedicales.fr/mesh/D007790",
"about": {
"@type": "MedicalCondition",
"name": "Lactosylcéramides",
"code": {
"@type": "MedicalCode",
"code": "D007790",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D10.570.877.360.612.200.612"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Trihexosylcéramide",
"alternateName": "Trihexosylceramides",
"url": "https://questionsmedicales.fr/mesh/D014281",
"about": {
"@type": "MedicalCondition",
"name": "Trihexosylcéramide",
"code": {
"@type": "MedicalCode",
"code": "D014281",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D10.570.877.360.612.200.906"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Sphingomyéline",
"alternateName": "Sphingomyelins",
"url": "https://questionsmedicales.fr/mesh/D013109",
"about": {
"@type": "MedicalCondition",
"name": "Sphingomyéline",
"code": {
"@type": "MedicalCode",
"code": "D013109",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D10.570.877.360.612.870"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Psychosine",
"alternateName": "Psychosine",
"url": "https://questionsmedicales.fr/mesh/D011609",
"about": {
"@type": "MedicalCondition",
"name": "Psychosine",
"code": {
"@type": "MedicalCode",
"code": "D011609",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D10.570.877.360.806"
}
}
}
]
}
],
"about": {
"@type": "MedicalCondition",
"name": "Sphingolipides",
"alternateName": "Sphingolipids",
"code": {
"@type": "MedicalCode",
"code": "D013107",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Erich Gulbins",
"url": "https://questionsmedicales.fr/author/Erich%20Gulbins",
"affiliation": {
"@type": "Organization",
"name": "Department of Molecular Biology, University of Duisburg-Essen, Essen, Germany."
}
},
{
"@type": "Person",
"name": "Giovanni D'Angelo",
"url": "https://questionsmedicales.fr/author/Giovanni%20D%27Angelo",
"affiliation": {
"@type": "Organization",
"name": "Interfaculty Institute of Bioengineering, Ecole polytechnique fédérale de Lausanne (EPFL), 1015 Lausanne, Switzerland giovanni.dangelo@epfl.ch Christopher.Clarke@stonybrookmedicine.edu lianacsilva@ff.ulisboa.pt."
}
},
{
"@type": "Person",
"name": "Anna Kovilakath",
"url": "https://questionsmedicales.fr/author/Anna%20Kovilakath",
"affiliation": {
"@type": "Organization",
"name": "Department of Human and Molecular Genetics, Virginia Commonwealth University, Richmond, VA, United States."
}
},
{
"@type": "Person",
"name": "L Ashley Cowart",
"url": "https://questionsmedicales.fr/author/L%20Ashley%20Cowart",
"affiliation": {
"@type": "Organization",
"name": "Department of Biochemistry and Molecular Biology and the Massey Cancer Center, Virginia Commonwealth University, Richmond, VA, United States."
}
},
{
"@type": "Person",
"name": "Tyrone Dowdy",
"url": "https://questionsmedicales.fr/author/Tyrone%20Dowdy",
"affiliation": {
"@type": "Organization",
"name": "Neuro-Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD 20814, USA."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Spatial Transcriptomics Identifies Cellular and Molecular Characteristics of Scleroderma Skin Lesions: Pilot Study in Juvenile Scleroderma.",
"datePublished": "2024-08-23",
"url": "https://questionsmedicales.fr/article/39273131",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3390/ijms25179182"
}
},
{
"@type": "ScholarlyArticle",
"name": "Pulmonary Hypertension in Scleroderma- Evaluation and Management.",
"datePublished": "2022-09-24",
"url": "https://questionsmedicales.fr/article/36163292",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.disamonth.2022.101468"
}
},
{
"@type": "ScholarlyArticle",
"name": "Cohort Enrichment Strategies for Progressive Interstitial Lung Disease in Systemic Sclerosis From European Scleroderma Trials and Research.",
"datePublished": "2022-10-14",
"url": "https://questionsmedicales.fr/article/36244404",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.chest.2022.09.044"
}
},
{
"@type": "ScholarlyArticle",
"name": "Standardized incidence ratios and risk factors for cancer in patients with systemic sclerosis: Data from the Spanish Scleroderma Registry (RESCLE).",
"datePublished": "2022-08-02",
"url": "https://questionsmedicales.fr/article/35931315",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.autrev.2022.103167"
}
},
{
"@type": "ScholarlyArticle",
"name": "Scleroderma autoantibodies in guiding monitoring and treatment decisions.",
"datePublished": "2022-08-29",
"url": "https://questionsmedicales.fr/article/36082759",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1097/BOR.0000000000000904"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Lipides",
"item": "https://questionsmedicales.fr/mesh/D008055"
},
{
"@type": "ListItem",
"position": 3,
"name": "Lipides membranaires",
"item": "https://questionsmedicales.fr/mesh/D008563"
},
{
"@type": "ListItem",
"position": 4,
"name": "Sphingolipides",
"item": "https://questionsmedicales.fr/mesh/D013107"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Sphingolipides - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Sphingolipides",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-12",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Sphingolipides",
"description": "Comment diagnostiquer une maladie liée aux sphingolipides ?\nQuels tests sont utilisés pour évaluer les sphingolipides ?\nLes symptômes peuvent-ils indiquer un déséquilibre des sphingolipides ?\nQuelle imagerie est utile pour les maladies des sphingolipides ?\nLes antécédents familiaux sont-ils importants pour le diagnostic ?",
"url": "https://questionsmedicales.fr/mesh/D013107?mesh_terms=Scleroderma,+Systemic&page=2#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Sphingolipides",
"description": "Quels sont les symptômes des troubles liés aux sphingolipides ?\nLes troubles digestifs sont-ils associés aux sphingolipides ?\nComment les sphingolipides affectent-ils le système nerveux ?\nLes troubles de la peau sont-ils fréquents avec les sphingolipides ?\nLes symptômes varient-ils selon le type de sphingolipide ?",
"url": "https://questionsmedicales.fr/mesh/D013107?mesh_terms=Scleroderma,+Systemic&page=2#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Sphingolipides",
"description": "Peut-on prévenir les maladies liées aux sphingolipides ?\nLes tests génétiques aident-ils à la prévention ?\nL'éducation sur les sphingolipides est-elle importante ?\nLes habitudes alimentaires influencent-elles la santé des sphingolipides ?\nLes vaccinations peuvent-elles aider à prévenir des complications ?",
"url": "https://questionsmedicales.fr/mesh/D013107?mesh_terms=Scleroderma,+Systemic&page=2#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Sphingolipides",
"description": "Quels traitements existent pour les maladies des sphingolipides ?\nLa diète peut-elle influencer les niveaux de sphingolipides ?\nLes médicaments peuvent-ils réduire les symptômes ?\nY a-t-il des traitements expérimentaux pour ces maladies ?\nLa thérapie génique est-elle une option pour ces maladies ?",
"url": "https://questionsmedicales.fr/mesh/D013107?mesh_terms=Scleroderma,+Systemic&page=2#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Sphingolipides",
"description": "Quelles complications peuvent survenir avec les troubles des sphingolipides ?\nLes troubles respiratoires sont-ils une complication possible ?\nComment les sphingolipides affectent-ils le cœur ?\nLes complications neurologiques sont-elles fréquentes ?\nLes complications peuvent-elles être réversibles ?",
"url": "https://questionsmedicales.fr/mesh/D013107?mesh_terms=Scleroderma,+Systemic&page=2#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Sphingolipides",
"description": "Quels sont les facteurs de risque pour les maladies des sphingolipides ?\nL'âge influence-t-il le risque de troubles des sphingolipides ?\nLes maladies auto-immunes sont-elles un facteur de risque ?\nLe mode de vie influence-t-il le risque ?\nLes infections peuvent-elles aggraver les troubles des sphingolipides ?",
"url": "https://questionsmedicales.fr/mesh/D013107?mesh_terms=Scleroderma,+Systemic&page=2#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une maladie liée aux sphingolipides ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic repose sur des tests génétiques, des analyses biochimiques et des biopsies."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour évaluer les sphingolipides ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests sanguins et des analyses d'urine mesurent les niveaux de sphingolipides."
}
},
{
"@type": "Question",
"name": "Les symptômes peuvent-ils indiquer un déséquilibre des sphingolipides ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des symptômes neurologiques ou cutanés peuvent signaler un déséquilibre."
}
},
{
"@type": "Question",
"name": "Quelle imagerie est utile pour les maladies des sphingolipides ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'IRM et la TDM peuvent aider à visualiser les effets des maladies sur les organes."
}
},
{
"@type": "Question",
"name": "Les antécédents familiaux sont-ils importants pour le diagnostic ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les antécédents familiaux peuvent indiquer une prédisposition génétique aux maladies."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes des troubles liés aux sphingolipides ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent des troubles neurologiques, des problèmes cutanés et des douleurs."
}
},
{
"@type": "Question",
"name": "Les troubles digestifs sont-ils associés aux sphingolipides ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certains troubles digestifs peuvent être liés à des anomalies des sphingolipides."
}
},
{
"@type": "Question",
"name": "Comment les sphingolipides affectent-ils le système nerveux ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Ils jouent un rôle dans la myélinisation et la signalisation neuronale, affectant la fonction nerveuse."
}
},
{
"@type": "Question",
"name": "Les troubles de la peau sont-ils fréquents avec les sphingolipides ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des affections cutanées comme l'eczéma peuvent être liées à des déséquilibres."
}
},
{
"@type": "Question",
"name": "Les symptômes varient-ils selon le type de sphingolipide ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les symptômes dépendent du type de sphingolipide impliqué et de l'organe affecté."
}
},
{
"@type": "Question",
"name": "Peut-on prévenir les maladies liées aux sphingolipides ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "La prévention est difficile, mais un mode de vie sain peut réduire les risques."
}
},
{
"@type": "Question",
"name": "Les tests génétiques aident-ils à la prévention ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les tests génétiques peuvent identifier les personnes à risque et guider la prévention."
}
},
{
"@type": "Question",
"name": "L'éducation sur les sphingolipides est-elle importante ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, comprendre les sphingolipides aide à reconnaître les symptômes et à agir rapidement."
}
},
{
"@type": "Question",
"name": "Les habitudes alimentaires influencent-elles la santé des sphingolipides ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une alimentation équilibrée peut soutenir la santé des sphingolipides et prévenir des troubles."
}
},
{
"@type": "Question",
"name": "Les vaccinations peuvent-elles aider à prévenir des complications ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines vaccinations peuvent prévenir des infections qui aggravent les troubles liés aux sphingolipides."
}
},
{
"@type": "Question",
"name": "Quels traitements existent pour les maladies des sphingolipides ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les traitements incluent des thérapies enzymatiques, des médicaments et des soins symptomatiques."
}
},
{
"@type": "Question",
"name": "La diète peut-elle influencer les niveaux de sphingolipides ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une alimentation riche en acides gras essentiels peut aider à réguler les sphingolipides."
}
},
{
"@type": "Question",
"name": "Les médicaments peuvent-ils réduire les symptômes ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certains médicaments peuvent atténuer les symptômes et améliorer la qualité de vie."
}
},
{
"@type": "Question",
"name": "Y a-t-il des traitements expérimentaux pour ces maladies ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des essais cliniques explorent de nouvelles thérapies pour les troubles des sphingolipides."
}
},
{
"@type": "Question",
"name": "La thérapie génique est-elle une option pour ces maladies ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "La thérapie génique est en recherche pour traiter certaines maladies liées aux sphingolipides."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir avec les troubles des sphingolipides ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent des troubles neurologiques graves, des infections et des défaillances organiques."
}
},
{
"@type": "Question",
"name": "Les troubles respiratoires sont-ils une complication possible ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certains troubles des sphingolipides peuvent entraîner des complications respiratoires."
}
},
{
"@type": "Question",
"name": "Comment les sphingolipides affectent-ils le cœur ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des déséquilibres peuvent contribuer à des maladies cardiovasculaires et à des arythmies."
}
},
{
"@type": "Question",
"name": "Les complications neurologiques sont-elles fréquentes ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des complications comme la démence ou des troubles moteurs peuvent survenir."
}
},
{
"@type": "Question",
"name": "Les complications peuvent-elles être réversibles ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines complications peuvent être gérées, mais d'autres peuvent être irréversibles."
}
},
{
"@type": "Question",
"name": "Quels sont les facteurs de risque pour les maladies des sphingolipides ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent des antécédents familiaux, des mutations génétiques et des déséquilibres nutritionnels."
}
},
{
"@type": "Question",
"name": "L'âge influence-t-il le risque de troubles des sphingolipides ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certains troubles apparaissent plus fréquemment chez les enfants ou les personnes âgées."
}
},
{
"@type": "Question",
"name": "Les maladies auto-immunes sont-elles un facteur de risque ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines maladies auto-immunes peuvent augmenter le risque de troubles liés aux sphingolipides."
}
},
{
"@type": "Question",
"name": "Le mode de vie influence-t-il le risque ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un mode de vie sédentaire et une mauvaise alimentation augmentent le risque."
}
},
{
"@type": "Question",
"name": "Les infections peuvent-elles aggraver les troubles des sphingolipides ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines infections peuvent exacerber les symptômes et les complications."
}
}
]
}
]
}
Juvenile localized and systemic scleroderma are rare autoimmune diseases which cause significant disability and morbidity in children. The mechanisms driving juvenile scleroderma remain unclear, neces...
Pulmonary Arterial Hypertension (PAH) is a clinical syndrome consisting of physiologic/hemodynamic criteria that are a consequence of several etiologies. Systemic Sclerosis (SSc), one of the most comm...
Enrichment strategies from clinical trials for progressive systemic sclerosis-associated interstitial lung disease (SSc-ILD) have not been tested in a real-life cohort....
Do enrichment strategies for progressive ILD impact efficacy, representativeness, and feasibility in patients with SSc-ILD from the European Scleroderma Trials and Research (EUSTAR) database?...
We applied the inclusion criteria of major recent SSc-ILD trials (Study of the Efficacy and Safety of Tocilizumab in Participants With Systemic Sclerosis [focuSSced], Scleroderma Lung Study II [SLS II...
In total, 2,258 patients with SSc-ILD were included: 31.2% of the patients met SENSCIS criteria; 5.8% of the patients met SLS II criteria; 1.6% of the patients met focuSSced criteria, and 67.7% (1,529...
The application of enrichment criteria from previous clinical trials showed enrichment for progression with variable success, which led to selected patient populations reducing feasibility of recruitm...
Patients with systemic sclerosis (SSc) are at increased risk of cancer, a growing cause of non-SSc-related death among these patients. We analyzed the increased cancer risk among Spanish patients with...
Spanish Scleroderma Registry data were analyzed to determine the demographic characteristics of patients with SSc, and logistic regression was used to identify cancer risk factors. SIRs with 95% confi...
Of 1930 patients with SSc, 206 had cancer, most commonly breast, lung, hematological, and colorectal cancers. Patients with SSc had increased risks of overall cancer (SIR 1.48, 95% CI 1.36-1.60; P < 0...
Spanish patients with SSc had an increased cancer risk compared with the general population. Some characteristics, including specific autoantibodies, may be related to this increased risk....
One of the key clinical challenges of systemic sclerosis (SSc) is diversity in clinical presentation, organ involvement and disease progression. Antinuclear autoantibodies (ANA) are central to the dia...
There has been further development in delineating clinical patterns in ANA, genetic susceptibility and antigen triggers predisposing to ANA subtypes. Sub-group analysis of recent clinical trials shows...
ANA subtyping is likely to be firmly embedded into future classification systems. Beyond informing current management and monitoring of scleroderma patients, ANA subsets have implication on future res...
The mechanisms of systemic autoimmune diseases (ADs) are still not clearly understood. Understanding the etiology of systemic ADs and identifying new therapeutic targets require a systems science appr...
People with systemic sclerosis (SSc) are vulnerable in COVID-19 and face challenges related to shifting COVID-19 risk and protective restrictions. We evaluated mental health symptom trajectories in pe...
The longitudinal Scleroderma Patient-centred Intervention Network (SPIN) COVID-19 cohort was launched in April 2020 and included participants from the ongoing SPIN Cohort and external enrolees. Analys...
Anxiety symptoms increased in early 2020 but returned to pre-COVID-19 levels by mid-2020 and remained stable through March 2022. Depression symptoms did not initially change but were slightly lower by...
People with SSc continue to face COVID-19 challenges related to ongoing risk, the opening of societies, and removal of protective restrictions. People with SSc, in aggregate, appear to be weathering t...
Systemic sclerosis (SSc) is a rare auto-immune disease, affecting principally women between 40 and 60 years old. It is caracterised by a cutaneous and visceral fibrosis, an alteration of the microvasc...
We have analysed the data of a retrospective and bicentrique cohort, from the internal medicine unit of Hôpital Nord in Marseille and from the internal medicine unit of the Hôpital Sainte-Anne in Toul...
The cohort included 151 patients including 134 limited cutaneous SSc. Fifty-two (34.4%) patients presented at least one associated auto-immune or inflammatory disease. The association of two connectiv...
SSc is often associated with other autoimmune diseases. This interrelation between associated pathologies and SSc, modifying sometimes the evolution of SSc, enhances the need of a personalized follow-...
Systemic sclerosis (SSc) represents extremely rare disease with majority of data coming from adults. Studies comparing juvenile- (jSSc) and adult-onset (aSSc) patients are limited. We aimed to compare...
A retrospective study among pediatric and adult Scl patients has been performed. Demographic characteristics, clinical features, autoantibody profiles, and treatment data were retrieved from the datab...
A total of 158 adults and 58 juvenile Scl patients were identified. The mean age at the disease onset was 37±14.7 vs. 8.8 ± 4.1 years, mean age at diagnosis 42±15.2 vs. 10.4 ± 3.8 years and mean follo...
Juvenile and adult-onset Scl represent rarely seen conditions with different clinical phenotypes. Pediatric patients with LS are more commonly seen by pediatric rheumatologists, in contrary to adults....
Systemic sclerosis (SSc), also known as scleroderma, is a chronic autoimmune connective tissue disease and is associated with a significant economic burden resulting from health care utilization costs...